Evidence map›Paper›PMID 39189871›Full record

ReviewPhysiology (Bethesda, Md.)2025

Harnessing Deep Learning Methods for Voltage-Gated Ion Channel Drug Discovery.

Diego Lopez-Mateos, Brandon John Harris, Adriana Hernández-González, Kush Narang, Vladimir Yarov-Yarovoy

Abstract readReview
In one paragraph

Review in Physiology (Bethesda, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diego Lopez-MateosDepartment of Physiology and Membrane Biology, University of California School of Medicine, Davis, California, United States.ORCID 0000-0002-8627-7208
Brandon John HarrisDepartment of Physiology and Membrane Biology, University of California School of Medicine, Davis, California, United States.ORCID 0000-0003-3894-0180
Adriana Hernández-GonzálezDepartment of Physiology and Membrane Biology, University of California School of Medicine, Davis, California, United States.
Kush NarangDepartment of Physiology and Membrane Biology, University of California School of Medicine, Davis, California, United States.
Vladimir Yarov-YarovoyDepartment of Physiology and Membrane Biology, University of California School of Medicine, Davis, California, United States.ORCID 0000-0002-2325-4834

Funding

UC Davis MCB T32 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) MentorshipT32GM007377 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEDIN, FREDERIC LOUIS · 1985 to 2023
$9.9M
In silico Safety PharmacologyR01HL128537 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CLANCY, COLLEEN E, SANTANA, LUIS F · 2016 to 2024
$5.7M
Deep-learning methods based computational modelingR01NS128180 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Juan Du, VLADIMIR M YAROV-YAROVOY · 2022 to 2026
$3.3M
Lipid regulation of Cardiac Excitation-Contraction couplingR01HL159304 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DIXON, ROSE ELLEN · 2022 to 2025
$2.4M
Multi-Scale Modeling of Vascular Signaling UnitsR01HL152681 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CLANCY, COLLEEN E, SANTANA, LUIS F · 2020 to 2023
$2.4M
Structural mechanism of polymodal TRP channel activationR01NS103954 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI YAROV-YAROVOY, VLADIMIR M, ZHENG, JIE · 2018 to 2022
$1.7M
Investigating the contributions of voltage gated sodium channels to oxaliplatin induced neuropathyR61NS127285 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WULFF, HEIKE, YAROV-YAROVOY, VLADIMIR M · 2022 to 2022
$1.6M
Activation and desensitization of heat-sensor TRPV1R01GM132110 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI YAROV-YAROVOY, VLADIMIR M, ZHENG, JIE · 2019 to 2022
$1.5M
Structural mechanism of thermoTRP channels activationR56NS097906 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI YAROV-YAROVOY, VLADIMIR M, ZHENG, JIE · 2017 to 2017
$481k
Design of de novo peptides and electrophysiological testing for voltage-gated sodium channel 1.7 inhibition related to chronic pain treatmentF31NS124337 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HARRIS, BRANDON JOHN · 2022 to 2024
$117k
HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL128537HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL159304HHS | NIH | National Institute of General Medical Sciences (NIGMS) R01GM132110HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32GM007377HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) F31NS124337HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS128180HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R56NS9706HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R61NS127285NHLBI NIH HHS R01 HL128537NHLBI NIH HHS R01 HL152681NHLBI NIH HHS R01 HL159304NIGMS NIH HHS R01 GM132110NIGMS NIH HHS T32 GM007377NINDS NIH HHS F31 NS124337NINDS NIH HHS R01 NS103954NINDS NIH HHS R01 NS128180NINDS NIH HHS R56 NS097906NINDS NIH HHS R61 NS127285
6 · The paper itself

Abstract

Voltage-gated ion channels (VGICs) are pivotal in regulating electrical activity in excitable cells and are critical pharmaceutical targets for treating many diseases including cardiac arrhythmia and neuropathic pain. Despite their significance, challenges such as achieving target selectivity persist in VGIC drug development. Recent progress in deep learning, particularly diffusion models, has enabled the computational design of protein binders for any clinically relevant protein based solely on its structure. These developments coincide with a surge in experimental structural data for VGICs, providing a rich foundation for computational design efforts. This review explores the recent advancements in computational protein design using deep learning and diffusion methods, focusing on their application in designing protein binders to modulate VGIC activity. We discuss the potential use of these methods to computationally design protein binders targeting different regions of VGICs, including the pore domain, voltage-sensing domains, and interface with auxiliary subunits. We provide a comprehensive overview of the different design scenarios, discuss key structural considerations, and address the practical challenges in developing VGIC-targeting protein binders. By exploring these innovative computational methods, we aim to provide a framework for developing novel strategies that could significantly advance VGIC pharmacology and lead to the discovery of effective and safe therapeutics.

Indexed as

Deep LearningDrug DiscoveryAnimalsHumansIon ChannelsIon ChannelsAlphaFolddeep learning methodsdrug discoveryion channelsprotein designRosetta

Identifiers

PMID39189871
PMCPMC11918310

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.